Celularity Announces $45 Million Purchase Order, First Middle East Private Label Agreement For Celularity’s Halal-Certified Biomaterial Products
Celularity biomaterial products are manufactured in its state-of-the-art cGMP/cGTP compliant facility located in Florham Park, New Jersey
- Celularity biomaterial products are manufactured in its state-of-the-art cGMP/cGTP compliant facility located in Florham Park, New Jersey
FLORHAM PARK, N.J., May 23, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (Celularity), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products, today announced that it has received a $45 million purchase order for Celularity private label Halal-Certified biomaterial products from Jamjoom Medical Store (Jamjoom). - This marks the first purchase order received by Celularity under its recently announced expansion into the Middle East market, as part of Celularity’s global market strategy.
- “We are delighted today to announce receipt of a $45 million purchase order for private label Celularity Halal-Certified biomaterial products from Jamjoom.
- “We are excited to partner with Jamjoom as the first private label distributor of these products in the Kingdom.”